Literature DB >> 2741945

Genetic studies of human apolipoproteins. IX. Apolipoprotein D polymorphism and its relation to serum lipoprotein lipid levels.

M I Kamboh1, J J Albers, P P Majumder, R E Ferrell.   

Abstract

Apolipoprotein D (APO D) is a constituent of plasma high-density lipoproteins. Its precise role in lipid metabolism is not well established, though it may be involved in cholesterol esterification and cholester ester transport to the liver for catabolism. No genetic polymorphism has been reported in the APO D gene product. To investigate the extent of genetic variation at the APO D structural locus, we have developed an isoelectric focusing-immunoblotting technique and have screened a large number of plasma samples from U.S. whites, U.S. blacks, Nigerian blacks, the Aleuts of the Pribilof Islands, Eskimo groups from Kodiak Island and St. Lawrence Island, and Amerindian populations from Mexico and Canada. Except for the U.S. blacks and Nigerian blacks, the APO D locus is monomorphic in all other population groups tested. In populations with black ancestry, the products of two alleles, APO D*1 and APO D*2, have been observed at respective allele frequencies .987 and .013 in U.S. blacks and .978 and .022 in Nigerian blacks. The detection of a unique protein polymorphism in blacks makes APO D a useful black marker of significance in anthropogenetics and racial admixture studies. In addition to the interindividual variation observed, APO D reveals extensive intraindividual molecular variation with a multiple banding pattern. The basis of this molecular variation is explained, in part, by variation in the number of terminal sialic acid residues. We have investigated the effect of the APO D polymorphism on triglycerides, total cholesterol, LDL-, VLDL-, HDL-, and HDL3 cholesterol in 352 Nigerian blacks (190 males and 162 females).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2741945      PMCID: PMC1683387     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  19 in total

1.  Genetic studies of human apolipoproteins. VI. Common polymorphism of apolipoprotein E in blacks.

Authors:  M I Kamboh; B Sepehrnia; R E Ferrell
Journal:  Dis Markers       Date:  1989 Jan-Mar       Impact factor: 3.434

2.  Genetic studies of low abundance human plasma proteins. II. Population genetics of coagulation factor XIIIB.

Authors:  M I Kamboh; R E Ferrell
Journal:  Am J Hum Genet       Date:  1986-12       Impact factor: 11.025

3.  Isolation and partial characterization of apolipoprotein D: a new protein moiety of the human plasma lipoprotein system.

Authors:  W J McConathy; P Alaupovic
Journal:  FEBS Lett       Date:  1973-12-01       Impact factor: 4.124

4.  Characterization and immunoassay of apolipoprotein D.

Authors:  J J Albers; M C Cheung; S L Ewens; J H Tollefson
Journal:  Atherosclerosis       Date:  1981-06       Impact factor: 5.162

5.  Reduction of lecithin-cholesterol acyltransferase, apolipoprotein D and the Lp(a) lipoprotein with the anabolic steroid stanozolol.

Authors:  J J Albers; H M Taggart; D Applebaum-Bowden; S Haffner; C H Chesnut; W R Hazzard
Journal:  Biochim Biophys Acta       Date:  1984-09-12

Review 6.  Apolipoprotein E polymorphism in health and disease.

Authors:  G Utermann
Journal:  Am Heart J       Date:  1987-02       Impact factor: 4.749

7.  Cloning and expression of human apolipoprotein D cDNA.

Authors:  D Drayna; C Fielding; J McLean; B Baer; G Castro; E Chen; L Comstock; W Henzel; W Kohr; L Rhee
Journal:  J Biol Chem       Date:  1986-12-15       Impact factor: 5.157

8.  Apolipoprotein D and cross-reacting human plasma apolipoproteins identified using monoclonal antibodies.

Authors:  P K Weech; R Camato; R W Milne; Y L Marcel
Journal:  J Biol Chem       Date:  1986-06-15       Impact factor: 5.157

9.  A cholesteryl ester transfer complex in human plasma.

Authors:  P E Fielding; C J Fielding
Journal:  Proc Natl Acad Sci U S A       Date:  1980-06       Impact factor: 11.205

10.  Epidemiological correlates of high density lipoprotein subfractions, apolipoproteins A-I, A-II, and D, and lecithin cholesterol acyltransferase. Effects of smoking, alcohol, and adiposity.

Authors:  S M Haffner; D Applebaum-Bowden; P W Wahl; J J Hoover; G R Warnick; J J Albers; W R Hazzard
Journal:  Arteriosclerosis       Date:  1985 Mar-Apr
View more
  9 in total

1.  Increased CNS levels of apolipoprotein D in schizophrenic and bipolar subjects: implications for the pathophysiology of psychiatric disorders.

Authors:  E A Thomas; B Dean; G Pavey; J G Sutcliffe
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

2.  Caucasian genes in American blacks: new data.

Authors:  R Chakraborty; M I Kamboh; M Nwankwo; R E Ferrell
Journal:  Am J Hum Genet       Date:  1992-01       Impact factor: 11.025

Review 3.  Dissecting the genetic contribution to coronary heart disease.

Authors:  J W MacCluer; C M Kammerer
Journal:  Am J Hum Genet       Date:  1991-12       Impact factor: 11.025

4.  Prenatal diagnosis of myotonic dystrophy using closely linked flanking markers.

Authors:  C Lavedan; H Hofmann; P Shelbourne; C Duros; D Savoy; K Johnson; C Junien
Journal:  J Med Genet       Date:  1991-02       Impact factor: 6.318

5.  A role of apolipoprotein D in triglyceride metabolism.

Authors:  German Perdomo; Dae Hyun Kim; Ting Zhang; Shen Qu; Elizabeth A Thomas; Frederico G S Toledo; Sandra Slusher; Yong Fan; David E Kelley; H Henry Dong
Journal:  J Lipid Res       Date:  2010-02-02       Impact factor: 5.922

6.  Predictive diagnosis of myotonic dystrophy with flanking microsatellite markers.

Authors:  J C Mulley; A K Gedeon; S J White; E A Haan; R I Richards
Journal:  J Med Genet       Date:  1991-07       Impact factor: 6.318

7.  Genetic studies of human apolipoproteins. XX. Genetic polymorphism of apolipoprotein J and its impact on quantitative lipid traits in normolipidemic subjects.

Authors:  M I Kamboh; J A Harmony; B Sepehrnia; M Nwankwo; R E Ferrell
Journal:  Am J Hum Genet       Date:  1991-12       Impact factor: 11.025

8.  Low level activity thresholds for changes in NMR biomarkers and genes in high risk subjects for Type 2 Diabetes.

Authors:  Karl-Heinz Herzig; Juhani Leppäluoto; Jari Jokelainen; Emmanuelle Meugnier; Sandra Pesenti; Harri Selänne; Kari A Mäkelä; Riikka Ahola; Timo Jämsä; Hubert Vidal; Sirkka Keinänen-Kiukaanniemi
Journal:  Sci Rep       Date:  2017-09-18       Impact factor: 4.379

Review 9.  Apolipoprotein D in lipid metabolism and its functional implication in atherosclerosis and aging.

Authors:  German Perdomo; H Henry Dong
Journal:  Aging (Albany NY)       Date:  2009-01       Impact factor: 5.682

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.